Literature DB >> 21336187

Combat-related craniofacial and cervical injuries: a 5-year review from the British military.

John Breeze1, Andrew J Gibbons, Colin Shieff, Graham Banfield, Douglas G Bryant, Mark J Midwinter.   

Abstract

BACKGROUND: Recent international publications have noted a sustained increase in the incidence of head, face, and neck (HFN) wounds in comparison with total battle injuries from the 20th to the 21st century. The aim of this review was therefore to perform an analysis of the epidemiology of all HFN injuries sustained by British forces in Iraq and Afghanistan from March 1, 2003, to December 31, 2008.
METHODS: Descriptive injury data for this research were obtained from the Joint Theater Trauma Registry and overall battle injury and evacuation figures from the Defense Analytical and Statistical Agency.
RESULTS: During this period, 448 servicemen sustained injuries to their HFN. A total of 71% of HFN injuries were sustained in battle. Of all service personnel sustaining HFN injuries, 32% died before the field hospital and a further 6% died subsequently. A total of 73% of injuries required evacuation back to the United Kingdom, whereas 27% of injuries were managed definitively in the theater of operations. HFN injuries altogether were found in 29% of battle injuries between 2006 and 2008.
CONCLUSIONS: The individual incidences of head (15%) and face (19%) injuries in relation to total battle injuries, although greater than seen in previous United Kingdom conflicts, were only slightly higher than that seen by US forces. The incidence of neck injury alone in relation to total battle injuries of 11% in United Kingdom forces in comparison with 3% to 5% found in US forces warrants further investigation. This article also provides further evidence to support the existing published opinion of multiple international authors in the requirement to develop innovative methods of protecting the vulnerable HFN regions.

Entities:  

Mesh:

Year:  2011        PMID: 21336187     DOI: 10.1097/TA.0b013e318203304a

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Role of ENT Surgeon in Managing Battle Trauma During Deployment.

Authors:  Renu Rajguru
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-11-29

2.  Implementation of a miniaturised navigation system in head and neck surgery for the detection and removal of foreign bodies.

Authors:  K J Lorenz; A Böckers; U Fassnacht; F Wilde; M Wegener
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-18       Impact factor: 2.503

3.  Management of Maxillofacial Gunshot Injuries With Emphasis on Damage Control Surgery During the Yemen Civil War. Review of 173 Victims From a Level 1 Trauma Hospital in Najran, Kingdom of Saudi Arabia.

Authors:  John S Daniels; Ibrahim Albakry; Ramat O Braimah; Mohammed I Samara; Rabea A Albalasi; Saleh M A Al-Rayshan
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2021-04-30

4.  Otological Manifestations in Head Injury: Experience from a Tertiary Academic Centre.

Authors:  Arulmozhi Sakthignanavel; Jayita Poduval; Mary Kurien
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-07

5.  Three-Dimensional Printing of Bone Extracellular Matrix for Craniofacial Regeneration.

Authors:  Ben P Hung; Bilal A Naved; Ethan L Nyberg; Miguel Dias; Christina A Holmes; Jennifer H Elisseeff; Amir H Dorafshar; Warren L Grayson
Journal:  ACS Biomater Sci Eng       Date:  2016-04-18

6.  Development of a skull/brain model for military wound ballistics studies.

Authors:  Debra Carr; Anne-Christine Lindstrom; Andreas Jareborg; Stephen Champion; Neil Waddell; David Miller; Michael Teagle; Ian Horsfall; Jules Kieser
Journal:  Int J Legal Med       Date:  2014-09-07       Impact factor: 2.686

7.  Facial injury management undertaken at US and UK medical treatment facilities during the Iraq and Afghanistan conflicts: a retrospective cohort study.

Authors:  John Breeze; Douglas M Bowley; James G Combes; James Baden; Rory F Rickard; Joseph DuBose; David B Powers
Journal:  BMJ Open       Date:  2019-11-25       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.